Analysis of the steps involved in Dengue virus entry into host cells.
The initial steps of dengue viral entry have been divided into adsorption and penetration using acid glycine treatment to inactivate extracellular virus after attachment to baby hamster kidney (BHK) cells but prior to penetration. First, we showed that virus infection was accomplished within 2 h after adsorption. Second, the assay was used to examine the properties of dengue envelope E protein-specific monoclonal antibodies (MAbs), lectins, and heparin. We found that three MAbs, 17-2, 46-9, and 51-3, may neutralize dengue 2 virus (DEN-2) through inhibition of not only viral attachment but also of penetration. However, one MAb, 56-3.1, interfered specifically with attachment. Therefore, the functional domains of E protein involved in attachment and penetration may be different. Moreover, studies with lectins indicated that carbohydrates, especially alpha-mannose residues, present on the virion glycoproteins may contribute to binding and penetration of the virus into BHK and mosquito C6/36 cells. Finally, virus infectivity was inhibited by heparin through its blocking effects at both virus attachment and penetration. This suggests that cell surface heparan sulfate functions in both viral attachment and penetration of DEN-2 virus. In conclusion, our results further elucidated some aspects of the dengue virus entry process.
Hung
S L
SL
Institute of Oral Biology, National Yang-Ming University, Taipei, Taiwan. slhung@ym.edu.tw
Lee
P L
PL
Chen
H W
HW
Chen
L K
LK
Kao
C L
CL
King
C C
CC
D000327:Adsorption; D000330:Aedes; D000818:Animals; D000911:Antibodies, Monoclonal; D050260:Carbohydrate Metabolism; D002241:Carbohydrates / Q000032:analysis; D002460:Cell Line; D002472:Cell Transformation, Viral / Q000187:drug effects; D003208:Concanavalin A / Q000494:pharmacology; D006224:Cricetinae; D003716:Dengue Virus / Q000187:drug effects / Q000472:pathogenicity*; D005998:Glycine / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D014759:Viral Envelope Proteins / Q000276:immunology / Q000502:physiology; D017361:Viral Nonstructural Proteins / Q000276:immunology / Q000502:physiology; D014764:Viral Proteins / Q000737:chemistry / Q000378:metabolism
D000911:Antibodies, Monoclonal; D002241:Carbohydrates; C082515:NS1 protein, dengue-1 virus; D014759:Viral Envelope Proteins; D017361:Viral Nonstructural Proteins; D014764:Viral Proteins; D003208:Concanavalin A; C072281:E protein TH Sman, Dengue virus; D006493:Heparin; D005998:Glycine